News About: Pharm. Industry
Huons signs $8 million export deal
Huons said on October 12 that it has signed an exclusive agreement with a Mexio-based company to export $8 million worth of platelet-rich plasma kit, a medical device to separate platelet and growth factors from the b...
Yungjin files patent application for novel time release formulation technology
Yungjin Pharm announced on October 11 that it has recently filed its patent applications for novel sustained-release technology at home and abroad.
“This patent invention relates to pharmaceutically active formulat...
KFDA likely to ban sibutramine-based drugs
The Korea Food and Drug Administration (KFDA), which reaffirmed the safety and distribution of sibutramine-based drugs in July, announced its plan on October 9 to review the substance once again after much criticism a...
Ildong completes KGMP plant for cephalosporin
Ildong Pharm said recently it has newly constructed a KGMP-accredited plant by investing 70 billion won to produce cephalosporin antibiotics and cancer drugs.
“To expand the overseas markets, we have built a new pl...
Debate reignited over IPA-containing painkillers
Lawmakers are urging health authorities to take a harder at safety concerns regarding painkillers containing isopropylantipyrine (IPA), a substance that has been linked to side effects including cardiovascular disorde...
Drugmakers likely to provide less financial aid to local academic conferences
60 pharmaceutical firms and medical instrument makers sponsored the autumn academic congress organized by the Korean Society of Cadiology, it was learned on October 7.
However, observers said that the organizers of...
Green Cross to conduct phase 1 trial for MGAH22 in HER2-positive carcinoma
Green Cross Corp. says it will conduct phase 1 study for MGAH22 (trastuzumab) after approval of the Korea Food and Drug Administration on October 8.
Developed by the U.S. based MacroGenics Inc., MGAH22 is a next-ge...
More pharmaceutical employees to face layoff
The new drug-pricing reform will hit the job market for those involved in the local pharmaceutical and wholesaling camps, leading to high job instability.
Under the cash reward plan for doctors and pharmacists, so...
R&D-oriented pharmaceutical firms to benefit from exemption of drug price cut
The drug price cut will be significantly exempted for drugmakers who intend to spend more money on the research and development (R&D) of new drugs, according to the Ministry of Health and Welfare.
Pharmaceutical ma...
Pharmaceutical firms sweating over 2011 plan
Many Korean pharmaceutical companies are struggling to finalize their business plans for the new year, an industry survey found recently.
A new drug-pricing reform has led many companies to say they have no plans ...
